Skip to main content
OpenTrials
Completed

NCT Number: NCT05516238

Systematic Use of Telepsychiatry for Outpatients

Implementation and evaluation of video consultation in psychiatric outpatient treatment. The study will focus on patients' experiences regarding the use of VC. The study will also examine important aspects of the telepsychiatric consultation such as therapeutic alliance, consultation content, psychopathology and satisfaction levels compared to face-to-face consultations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Borderline Personality Disorder Anxiety Disorders Depressive Disorder Mental Disorders Mood Disorders PTSD Personality Disorders Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Psychiatric research unit, Region Zealand,

Slagelse, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age > 18 years
  • Danish-speaking.

Exclusion criteria

  • Exclusion criteria included a diagnosis of schizophrenia or bipolar disorder, or suffering from substance abuse.
  • Additionally, Participants in the VC group were excluded if they did not have a smartphone, tablet, laptop, or personal computer with a webcam.

Treatment and study plan

Case management

Other

Case management cover therapy (psychotherapy/psychoeducation), medication adjustment, training in daily living skills (supportive), and direct consultations in crises.

Primary outcomes

  1. The demand for video consultation (VC) in clinical practice.

    Time frame: One year

    The demand for VC is evaluated by the percentage of included participants who chose to be in the VC group and the actual use of VC consultation sessions during the study period, including the number of missed appointments and the number of times VC sessions have been converted to telephone or in-person (IP) consultations.

  2. Patients' therapeutic alliance, assessed by working alliance inventory- client version (WAI-C)

    Time frame: Two months.

    Therapeutic alliance is evaluated with the mean change scores in the WAI-C questionnaire at baseline and posttreatment. Score ranging: from 12 to 84. Higher scores indicate a higher therapeutic alliance

  3. Patients' satisfaction, assessed by client satisfaction questionnaire 8 (CSQ-8)

    Time frame: Two months.

    Satisfaction is evaluated with the mean change scores in the CSQ-8 questionnaire at baseline and posttreatment. Score ranging: from 8 to 32. Higher scores indicate a higher satisfaction

  4. Patients' Symptom level, assessed by Symptom Checklist -10 (SCL-10)

    Time frame: Two months.

    Symptom level is evaluated with the mean change scores in the SCL-10 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Lower score indicates lower psychological distress

  5. Patients' well-being, assessed by World Health Organisation- Five Well-Being Index (WHO-5)

    Time frame: Two months.

    Well-being level is evaluated with the mean change scores in the WHO-5 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Higher scores indicate higher well-being

  6. Patients' function, assessed by Sheehan Disability Scale (SDS)

    Time frame: Two months.

    Functional impairment is evaluated with the mean change scores in the SDS questionnaire at baseline and posttreatment. Score ranging: from 0 to 30. lower scores indicate lower functional impairment

  7. Patient recovery, assessed by INSPIRE

    Time frame: Two months.

    Patient recovery is evaluated with the mean change scores in the INSPIRE questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. A higher score indicates higher recovery

  8. The implementation and integration of VC in clinical practice, as assessed by a checklist developed for the case managers (CM).

    Time frame: One year

    The following properties are used to evaluate the implementation and integration properties:

    • type of technology patients use for VC sessions (Smartphone/tablet or personal computer/laptop)
    • patients' physical location during VC session (Home or outdoor)
    • the VC sessions confidentiality (Alone or with other persons)
    • duration of VC session
    • the content of the VC sessions (supportive, therapy, medication management, crisis/acute or "mix" content)

    Descriptive statistics will be applied to evaluate the implementation and integration properties.

  9. Patients' experiences regarding the use of VC

    Time frame: Two months

    Semistructured interviews have been conducted to evaluate participants' experience regarding the use of VC technology in clinical practice.

Sponsors and collaborators

Lead sponsor

Psychiatric Research Unit, Region Zealand, Denmark

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Aug 25, 2022
Registry last updated
Mar 31, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.